Guangdong Transtek Medical Stock EBITDA
| 300562 Stock | 12.38 0.95 7.13% |
Guangdong Transtek Medical fundamentals help investors to digest information that contributes to Guangdong Transtek's financial success or failures. It also enables traders to predict the movement of Guangdong Stock. The fundamental analysis module provides a way to measure Guangdong Transtek's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guangdong Transtek stock.
Guangdong |
Guangdong Transtek Medical Company EBITDA Analysis
Guangdong Transtek's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Guangdong Transtek EBITDA | 66.31 M |
Most of Guangdong Transtek's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guangdong Transtek Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Guangdong Transtek Medical reported earnings before interest,tax, depreciation and amortization of 66.31 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The ebitda for all China stocks is notably lower than that of the firm.
Guangdong EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guangdong Transtek's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guangdong Transtek could also be used in its relative valuation, which is a method of valuing Guangdong Transtek by comparing valuation metrics of similar companies.Guangdong Transtek is currently under evaluation in ebitda category among its peers.
Guangdong Fundamentals
| Return On Equity | 0.0634 | ||||
| Return On Asset | 0.0252 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 2.37 B | ||||
| Shares Outstanding | 217.47 M | ||||
| Shares Owned By Insiders | 37.18 % | ||||
| Shares Owned By Institutions | 2.10 % | ||||
| Price To Book | 2.80 X | ||||
| Price To Sales | 2.59 X | ||||
| Revenue | 884.26 M | ||||
| Gross Profit | 335.31 M | ||||
| EBITDA | 66.31 M | ||||
| Net Income | 31.2 M | ||||
| Total Debt | 134.98 M | ||||
| Book Value Per Share | 4.78 X | ||||
| Cash Flow From Operations | 74.14 M | ||||
| Earnings Per Share | 0.32 X | ||||
| Target Price | 13.7 | ||||
| Number Of Employees | 1.29 K | ||||
| Beta | 0.29 | ||||
| Market Capitalization | 2.68 B | ||||
| Total Asset | 1.56 B | ||||
| Retained Earnings | 234.31 M | ||||
| Working Capital | 509.88 M | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 1.56 B | ||||
| Last Dividend Paid | 0.28 |
About Guangdong Transtek Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guangdong Transtek Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guangdong Transtek using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guangdong Transtek Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Guangdong Stock
Guangdong Transtek financial ratios help investors to determine whether Guangdong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guangdong with respect to the benefits of owning Guangdong Transtek security.